CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CCDC112 | Coiled-coil domain containing 112 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCDC113 | Coiled-coil domain containing 113 | | | | | | Tissue enhanced |
CCDC15 | Coiled-coil domain containing 15 | | | | | | Tissue enhanced |
CCDC155 | Coiled-coil domain containing 155 | Predicted membrane proteins
| | | | | Tissue enriched |
CCDC181 | Coiled-coil domain containing 181 | | | | | | Tissue enhanced |
CCDC19 | Coiled-coil domain containing 19 | | | | | | Group enriched |
CCDC40 | Coiled-coil domain containing 40 | Disease related genes
| | | | | Tissue enhanced |
CCNB2 | Cyclin B2 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
CCNB3 | Cyclin B3 | | | | | | Tissue enhanced |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CDC20 | Cell division cycle 20 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
CDC45 | Cell division cycle 45 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CDKL5 | Cyclin-dependent kinase-like 5 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | | Group enriched |
CEBPE | CCAAT/enhancer binding protein (C/EBP), epsilon | Transcription factors
| | | | | Tissue enriched |
CES1 | Carboxylesterase 1 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CGB2 | Chorionic gonadotropin, beta polypeptide 2 | Predicted secreted proteins
| | | | | Tissue enriched |
CGB8 | Chorionic gonadotropin, beta polypeptide 8 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CGNL1 | Cingulin-like 1 | Disease related genes
| | | | | Tissue enhanced |
CLDN2 | Claudin 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLGN | Calmegin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLIC3 | Chloride intracellular channel 3 | Plasma proteins Transporters
| | | | | Group enriched |
CMTM2 | CKLF-like MARVEL transmembrane domain containing 2 | Predicted membrane proteins
| | | | | Tissue enriched |
CNP | 2',3'-cyclic nucleotide 3' phosphodiesterase | Enzymes Plasma proteins
| | | | | Tissue enriched |
COL4A2 | Collagen, type IV, alpha 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL8A1 | Collagen, type VIII, alpha 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CRABP2 | Cellular retinoic acid binding protein 2 | | | | | | Tissue enriched |
CRYAB | Crystallin, alpha B | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CSTA | Cystatin A (stefin A) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
CSTB | Cystatin B (stefin B) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Group enriched |
CTH | Cystathionase (cystathionine gamma-lyase) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
CXorf67 | Chromosome X open reading frame 67 | | | | | | Group enriched |
DAZL | Deleted in azoospermia-like | | | | | | Tissue enriched |
DCT | Dopachrome tautomerase | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
DDX20 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 | Cytoskeleton related proteins Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
DDX43 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 43 | Enzymes
| | | | | Tissue enriched |
DKK3 | Dickkopf WNT signaling pathway inhibitor 3 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DNAI1 | Dynein, axonemal, intermediate chain 1 | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
DNAJC6 | DnaJ (Hsp40) homolog, subfamily C, member 6 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
DSC3 | Desmocollin 3 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
DSP | Desmoplakin | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Group enriched |
DTL | Denticleless E3 ubiquitin protein ligase homolog (Drosophila) | | | | | | Tissue enhanced |
DYX1C1 | Dyslexia susceptibility 1 candidate 1 | Disease related genes
| | | | | Tissue enhanced |
E2F1 | E2F transcription factor 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
EFCAB4B | EF-hand calcium binding domain 4B | | | | | | Tissue enhanced |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |